Evidence map›Paper›PMID 24858952›Full record

Trial reportPloS one2014

Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial.

Matthew D Campbell, Mark Walker, Michael I Trenell, Steven Luzio, Gareth Dunseath, Daniel Tuner, Richard M Bracken, Stephen C Bain, Mark Russell, Emma J Stevenson and 1 more

2 registry-linked trialsOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01531855 nacompletednot on this map

The Metabolic and Glycaemic Responses to Reductions in Rapid-acting Insulin Dose After Running Exercise in People With Type 1 Diabetes Mellitus.

TypeinterventionalSponsorNorthumbria UniversityRan2012 to 2012Enrolled13ConditionsType 1 DiabetesArmsReducing post-exercise rapid-acting insulin (insulin lispro or aspart) dose
NCT02660242 phase2completednot on this mapstarted 2016, after this paper: background citation

The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes

TypeinterventionalSponsorJaeb Center for Health ResearchRan2016 to 2017Enrolled16ConditionsDiabetes Mellitus, Type 1ArmsG-Pen Mini™ (glucagon injection), Glucose Tabs, Basal Insulin Reduction
3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 91 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Tailoring Exercise Prescription for Effective Diabetes Glucose Management.The Journal of clinical endocrinology and metabolism · 2025
    Review
  4. Article
  5. Review
  6. Association of HbA1c with VOMetabolites · 2022
    Review
  7. Article
  8. Review
  9. Article
  10. Observational
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Observational
  19. Prevention of exercise-associated dysglycemia: a case study-based approach.Diabetes spectrum : a publication of the American Diabetes Association · 2015
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Matthew D CampbellDepartment of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle-upon-Tyne, United Kingdom.
Mark WalkerInstitute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
Michael I TrenellInstitute for Ageing and Health, Faculty of Medicine, Newcastle University, Newcastle-upon-Tyne, United Kingdom.
Steven LuzioDiabetes Research Group, College of Medicine, Swansea University Swansea, United Kingdom.
Gareth DunseathDiabetes Research Group, College of Medicine, Swansea University Swansea, United Kingdom.
Daniel TunerApplied Sports, Technology, Exercise and Medicine Research Centre, College of Engineering, Swansea University, Swansea, United Kingdom.
Richard M BrackenApplied Sports, Technology, Exercise and Medicine Research Centre, College of Engineering, Swansea University, Swansea, United Kingdom.
Stephen C BainDiabetes Research Group, College of Medicine, Swansea University Swansea, United Kingdom.
Mark RussellDepartment of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle-upon-Tyne, United Kingdom.
Emma J StevensonDepartment of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle-upon-Tyne, United Kingdom.
Daniel J WestDepartment of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University, Newcastle-upon-Tyne, United Kingdom.
Swansea University · GBNorthumbria University · GBNewcastle University · GB

Funding

Department of Health SRF-2011-04-017Medical Research Council MC_G0802536
6 · The paper itself

Abstract

aimTo examine the metabolic, gluco-regulatory-hormonal and inflammatory cytokine responses to large reductions in rapid-acting insulin dose administered prandially before and after intensive running exercise in male type 1 diabetes patients.

methodsThis was a single centre, randomised, controlled open label study. Following preliminary testing, 8 male patients (24±2 years, HbA1c 7.7±0.4%/61±4 mmol.l-1) treated with insulin's glargine and aspart, or lispro attended the laboratory on two mornings at ∼08:00 h and consumed a standardised breakfast carbohydrate bolus (1 g carbohydrate.kg-1BM; 380±10 kcal) and self-administered a 75% reduced rapid-acting insulin dose 60 minutes before 45 minutes of intensive treadmill running at 73.1±0.9% VO2peak. At 60 minutes post-exercise, patients ingested a meal (1 g carbohydrate.kg-1BM; 660±21 kcal) and administered either a Full or 50% reduced rapid-acting insulin dose. Blood glucose and lactate, serum insulin, cortisol, non-esterified-fatty-acids, β-Hydroxybutyrate, and plasma glucagon, adrenaline, noradrenaline, IL-6, and TNF-α concentrations were measured for 180 minutes post-meal.

resultsAll participants were analysed. All glycaemic, metabolic, hormonal, and cytokine responses were similar between conditions up to 60 minutes following exercise. Following the post-exercise meal, serum insulin concentrations were lower under 50% (p<0.05) resulting in 75% of patients experiencing hyperglycaemia (blood glucose ≥8.0 mmol.l-1; 50% n = 6, Full n = 3). β-Hydroxybutyrate concentrations decreased similarly, such that at 180 minutes post-meal concentrations were lower than rest under Full and 50%. IL-6 and TNF-α concentrations remained similar to fasting levels under 50% but declined under Full. Under 50% IL-6 concentrations were inversely related with serum insulin concentrations (r = -0.484, p = 0.017).

conclusionsHeavily reducing rapid-acting insulin dose with a carbohydrate bolus before, and a meal after intensive running exercise may cause hyperglycaemia, but does not augment ketonaemia, raise inflammatory cytokines TNF-α and IL-6 above fasting levels, or cause other adverse metabolic or hormonal disturbances.

trial registrationClinicalTrials.gov NCT01531855.

Indexed as

ExerciseBlood GlucoseDiabetes Mellitus, Type 1HumansHypoglycemiaInsulinInsulin, Short-ActingInterleukin-6MaleRestTime FactorsTumor Necrosis Factor-alphaYoung AdultBlood GlucoseInsulinInsulin, Short-ActingInterleukin-6Tumor Necrosis Factor-alpha

Identifiers

PMID24858952
PMCPMC4032262
OpenAlexW2123864627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.